nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfinpyrazone—ABCC3—lung cancer	0.298	0.832	CbGaD
Sulfinpyrazone—ABCC6—Teniposide—lung cancer	0.0786	0.143	CbGbCtD
Sulfinpyrazone—ABCB1—lung cancer	0.0602	0.168	CbGaD
Sulfinpyrazone—ABCC6—Vinblastine—lung cancer	0.0385	0.0699	CbGbCtD
Sulfinpyrazone—ABCC6—Cisplatin—lung cancer	0.0353	0.0641	CbGbCtD
Sulfinpyrazone—ABCC6—Etoposide—lung cancer	0.0347	0.063	CbGbCtD
Sulfinpyrazone—ABCC5—Cisplatin—lung cancer	0.027	0.049	CbGbCtD
Sulfinpyrazone—ABCC6—Doxorubicin—lung cancer	0.0236	0.043	CbGbCtD
Sulfinpyrazone—ABCC3—Cisplatin—lung cancer	0.017	0.0308	CbGbCtD
Sulfinpyrazone—ABCC3—Etoposide—lung cancer	0.0167	0.0303	CbGbCtD
Sulfinpyrazone—ABCC1—Paclitaxel—lung cancer	0.0129	0.0235	CbGbCtD
Sulfinpyrazone—ABCC1—Irinotecan—lung cancer	0.0128	0.0232	CbGbCtD
Sulfinpyrazone—ABCC3—Doxorubicin—lung cancer	0.0114	0.0206	CbGbCtD
Sulfinpyrazone—ABCC1—Vinblastine—lung cancer	0.0114	0.0206	CbGbCtD
Sulfinpyrazone—ABCC3—Methotrexate—lung cancer	0.011	0.02	CbGbCtD
Sulfinpyrazone—ABCC1—Etoposide—lung cancer	0.0102	0.0186	CbGbCtD
Sulfinpyrazone—ABCC2—Paclitaxel—lung cancer	0.00958	0.0174	CbGbCtD
Sulfinpyrazone—ABCC2—Irinotecan—lung cancer	0.00945	0.0172	CbGbCtD
Sulfinpyrazone—ABCC1—Docetaxel—lung cancer	0.00936	0.017	CbGbCtD
Sulfinpyrazone—ABCC4—Methotrexate—lung cancer	0.00841	0.0153	CbGbCtD
Sulfinpyrazone—ABCC2—Vinblastine—lung cancer	0.0084	0.0153	CbGbCtD
Sulfinpyrazone—ABCC2—Cisplatin—lung cancer	0.0077	0.014	CbGbCtD
Sulfinpyrazone—ABCC2—Etoposide—lung cancer	0.00757	0.0138	CbGbCtD
Sulfinpyrazone—ABCC1—Doxorubicin—lung cancer	0.00698	0.0127	CbGbCtD
Sulfinpyrazone—ABCC2—Docetaxel—lung cancer	0.00693	0.0126	CbGbCtD
Sulfinpyrazone—ABCC1—Methotrexate—lung cancer	0.00676	0.0123	CbGbCtD
Sulfinpyrazone—ABCB1—Topotecan—lung cancer	0.00631	0.0115	CbGbCtD
Sulfinpyrazone—CYP2B6—Irinotecan—lung cancer	0.00601	0.0109	CbGbCtD
Sulfinpyrazone—CYP2C9—Gefitinib—lung cancer	0.00595	0.0108	CbGbCtD
Sulfinpyrazone—ABCB1—Gefitinib—lung cancer	0.00577	0.0105	CbGbCtD
Sulfinpyrazone—CYP2C9—Teniposide—lung cancer	0.00577	0.0105	CbGbCtD
Sulfinpyrazone—ABCC2—Doxorubicin—lung cancer	0.00516	0.00938	CbGbCtD
Sulfinpyrazone—CYP2C8—Erlotinib—lung cancer	0.00504	0.00916	CbGbCtD
Sulfinpyrazone—ABCC2—Methotrexate—lung cancer	0.005	0.00909	CbGbCtD
Sulfinpyrazone—CYP2B6—Cisplatin—lung cancer	0.0049	0.0089	CbGbCtD
Sulfinpyrazone—CYP2C8—Paclitaxel—lung cancer	0.00461	0.00839	CbGbCtD
Sulfinpyrazone—ABCB1—Vinorelbine—lung cancer	0.00444	0.00808	CbGbCtD
Sulfinpyrazone—CYP3A4—Topotecan—lung cancer	0.00378	0.00687	CbGbCtD
Sulfinpyrazone—CYP2C8—Etoposide—lung cancer	0.00365	0.00663	CbGbCtD
Sulfinpyrazone—ABCB1—Crizotinib—lung cancer	0.00354	0.00643	CbGbCtD
Sulfinpyrazone—CYP3A4—Gefitinib—lung cancer	0.00346	0.00628	CbGbCtD
Sulfinpyrazone—ABCB1—Gemcitabine—lung cancer	0.00346	0.00628	CbGbCtD
Sulfinpyrazone—ABCB1—Erlotinib—lung cancer	0.00341	0.0062	CbGbCtD
Sulfinpyrazone—CYP3A4—Teniposide—lung cancer	0.00335	0.00609	CbGbCtD
Sulfinpyrazone—CYP2B6—Doxorubicin—lung cancer	0.00328	0.00597	CbGbCtD
Sulfinpyrazone—CYP2C9—Paclitaxel—lung cancer	0.00322	0.00585	CbGbCtD
Sulfinpyrazone—ABCB1—Paclitaxel—lung cancer	0.00312	0.00568	CbGbCtD
Sulfinpyrazone—ABCB1—Irinotecan—lung cancer	0.00308	0.0056	CbGbCtD
Sulfinpyrazone—ABCB1—Vinblastine—lung cancer	0.00274	0.00498	CbGbCtD
Sulfinpyrazone—CYP3A4—Vinorelbine—lung cancer	0.00266	0.00484	CbGbCtD
Sulfinpyrazone—CYP2C9—Cisplatin—lung cancer	0.00259	0.0047	CbGbCtD
Sulfinpyrazone—ABCB1—Cisplatin—lung cancer	0.00251	0.00456	CbGbCtD
Sulfinpyrazone—ABCB1—Etoposide—lung cancer	0.00247	0.00448	CbGbCtD
Sulfinpyrazone—ABCB1—Docetaxel—lung cancer	0.00226	0.0041	CbGbCtD
Sulfinpyrazone—CYP3A4—Crizotinib—lung cancer	0.00212	0.00385	CbGbCtD
Sulfinpyrazone—CYP3A4—Erlotinib—lung cancer	0.00204	0.00371	CbGbCtD
Sulfinpyrazone—FABP2—epithelium—lung cancer	0.00193	0.161	CbGeAlD
Sulfinpyrazone—CYP3A4—Paclitaxel—lung cancer	0.00187	0.0034	CbGbCtD
Sulfinpyrazone—CYP3A4—Irinotecan—lung cancer	0.00185	0.00335	CbGbCtD
Sulfinpyrazone—ABCB1—Doxorubicin—lung cancer	0.00168	0.00306	CbGbCtD
Sulfinpyrazone—CYP3A4—Vinblastine—lung cancer	0.00164	0.00298	CbGbCtD
Sulfinpyrazone—ABCB1—Methotrexate—lung cancer	0.00163	0.00296	CbGbCtD
Sulfinpyrazone—ABCC6—Podofilox—Teniposide—lung cancer	0.00155	0.627	CbGdCrCtD
Sulfinpyrazone—CYP3A4—Etoposide—lung cancer	0.00148	0.00269	CbGbCtD
Sulfinpyrazone—CYP3A4—Docetaxel—lung cancer	0.00135	0.00246	CbGbCtD
Sulfinpyrazone—CYP3A4—Doxorubicin—lung cancer	0.00101	0.00183	CbGbCtD
Sulfinpyrazone—ABCC5—mammary gland—lung cancer	0.00098	0.0822	CbGeAlD
Sulfinpyrazone—ABCC6—Podofilox—Etoposide—lung cancer	0.000922	0.373	CbGdCrCtD
Sulfinpyrazone—FABP2—lymph node—lung cancer	0.000837	0.0701	CbGeAlD
Sulfinpyrazone—Clotrimazole—ABCC3—lung cancer	0.000599	0.315	CrCbGaD
Sulfinpyrazone—ABCC3—respiratory system—lung cancer	0.000549	0.046	CbGeAlD
Sulfinpyrazone—ABCC5—bronchus—lung cancer	0.000538	0.0451	CbGeAlD
Sulfinpyrazone—ABCC6—lung—lung cancer	0.00051	0.0428	CbGeAlD
Sulfinpyrazone—CYP2C8—mammary gland—lung cancer	0.000493	0.0413	CbGeAlD
Sulfinpyrazone—ABCC5—cardiac atrium—lung cancer	0.000454	0.038	CbGeAlD
Sulfinpyrazone—CYP2C9—mammary gland—lung cancer	0.000438	0.0367	CbGeAlD
Sulfinpyrazone—ABCC5—bone marrow—lung cancer	0.000383	0.0321	CbGeAlD
Sulfinpyrazone—ABCC4—bronchus—lung cancer	0.000373	0.0312	CbGeAlD
Sulfinpyrazone—ABCC5—lung—lung cancer	0.000347	0.0291	CbGeAlD
Sulfinpyrazone—Clotrimazole—CYP2A6—lung cancer	0.000325	0.171	CrCbGaD
Sulfinpyrazone—ABCC1—bronchus—lung cancer	0.000318	0.0266	CbGeAlD
Sulfinpyrazone—CYP2B6—respiratory system—lung cancer	0.000295	0.0247	CbGeAlD
Sulfinpyrazone—ABCC3—lung—lung cancer	0.000291	0.0244	CbGeAlD
Sulfinpyrazone—ABCC1—trachea—lung cancer	0.000285	0.0239	CbGeAlD
Sulfinpyrazone—Cinnarizine—CYP2A6—lung cancer	0.000275	0.145	CrCbGaD
Sulfinpyrazone—ABCC1—cardiac atrium—lung cancer	0.000268	0.0225	CbGeAlD
Sulfinpyrazone—ABCC4—bone marrow—lung cancer	0.000265	0.0222	CbGeAlD
Sulfinpyrazone—CYP2B6—bronchus—lung cancer	0.000243	0.0203	CbGeAlD
Sulfinpyrazone—ABCC4—lung—lung cancer	0.00024	0.0202	CbGeAlD
Sulfinpyrazone—ABCC5—lymph node—lung cancer	0.000237	0.0199	CbGeAlD
Sulfinpyrazone—Clotrimazole—CYP2E1—lung cancer	0.000231	0.121	CrCbGaD
Sulfinpyrazone—ABCC1—lung—lung cancer	0.000205	0.0172	CbGeAlD
Sulfinpyrazone—ABCC3—lymph node—lung cancer	0.000199	0.0167	CbGeAlD
Sulfinpyrazone—Cinnarizine—CYP1A1—lung cancer	0.000193	0.101	CrCbGaD
Sulfinpyrazone—ABCC4—lymph node—lung cancer	0.000164	0.0138	CbGeAlD
Sulfinpyrazone—ABCC2—lymph node—lung cancer	0.000159	0.0133	CbGeAlD
Sulfinpyrazone—Phenylbutazone—PTGS2—lung cancer	0.000159	0.0835	CrCbGaD
Sulfinpyrazone—ABCB1—respiratory system—lung cancer	0.000158	0.0132	CbGeAlD
Sulfinpyrazone—CYP2B6—lung—lung cancer	0.000157	0.0131	CbGeAlD
Sulfinpyrazone—ABCC1—lymph node—lung cancer	0.00014	0.0118	CbGeAlD
Sulfinpyrazone—ABCB1—epithelium—lung cancer	0.000132	0.011	CbGeAlD
Sulfinpyrazone—Clotrimazole—ABCB1—lung cancer	0.000121	0.0636	CrCbGaD
Sulfinpyrazone—ABCB1—trachea—lung cancer	0.000117	0.00976	CbGeAlD
Sulfinpyrazone—ABCB1—bone marrow—lung cancer	9.24e-05	0.00774	CbGeAlD
Sulfinpyrazone—ABCB1—lung—lung cancer	8.37e-05	0.00702	CbGeAlD
Sulfinpyrazone—ABCB1—lymph node—lung cancer	5.73e-05	0.0048	CbGeAlD
Sulfinpyrazone—ABCC5—Disease—MAPK3—lung cancer	5.26e-06	6.98e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.25e-06	6.96e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CNDP2—lung cancer	5.25e-06	6.96e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTM2—lung cancer	5.25e-06	6.96e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	5.2e-06	6.9e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GSTT1—lung cancer	5.2e-06	6.89e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CYP2E1—lung cancer	5.16e-06	6.84e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PTEN—lung cancer	5.16e-06	6.84e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP2A6—lung cancer	5.14e-06	6.81e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GCLC—lung cancer	5.14e-06	6.81e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—UGT1A1—lung cancer	5.13e-06	6.8e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—MYC—lung cancer	5.12e-06	6.79e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.12e-06	6.78e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—MTMR3—lung cancer	5.11e-06	6.77e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—NQO1—lung cancer	5.1e-06	6.76e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—AKT1—lung cancer	5.08e-06	6.74e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—BRAF—lung cancer	5.05e-06	6.7e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PIK3CD—lung cancer	5.05e-06	6.69e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ALDOA—lung cancer	5.04e-06	6.68e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	5.01e-06	6.64e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—EGFR—lung cancer	5.01e-06	6.64e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—IL6R—lung cancer	4.99e-06	6.61e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—ALB—lung cancer	4.99e-06	6.61e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CREBBP—lung cancer	4.98e-06	6.6e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PGAM1—lung cancer	4.98e-06	6.59e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GNG11—lung cancer	4.95e-06	6.55e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—APOA1—lung cancer	4.93e-06	6.53e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—EP300—lung cancer	4.92e-06	6.52e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.92e-06	6.52e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NCOA3—lung cancer	4.89e-06	6.48e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ENO1—lung cancer	4.87e-06	6.45e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.85e-06	6.43e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.79e-06	6.35e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ABCG2—lung cancer	4.76e-06	6.31e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ADCY1—lung cancer	4.76e-06	6.31e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MAP2K1—lung cancer	4.76e-06	6.3e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP2A7—lung cancer	4.75e-06	6.29e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—KRAS—lung cancer	4.73e-06	6.27e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PIK3CD—lung cancer	4.73e-06	6.26e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.72e-06	6.26e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ALDOA—lung cancer	4.71e-06	6.24e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—HPGDS—lung cancer	4.67e-06	6.19e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ENO2—lung cancer	4.67e-06	6.19e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—SDC4—lung cancer	4.65e-06	6.16e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PPP2R1B—lung cancer	4.64e-06	6.15e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—STK11—lung cancer	4.6e-06	6.09e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NCOA3—lung cancer	4.57e-06	6.06e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GSTT1—lung cancer	4.53e-06	6e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CG—lung cancer	4.5e-06	5.97e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.49e-06	5.95e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP2A6—lung cancer	4.48e-06	5.93e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GCLC—lung cancer	4.48e-06	5.93e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ABCG2—lung cancer	4.45e-06	5.89e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ADCY1—lung cancer	4.45e-06	5.89e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PIK3CB—lung cancer	4.4e-06	5.83e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.39e-06	5.82e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP2E1—lung cancer	4.37e-06	5.79e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PTGS2—lung cancer	4.36e-06	5.78e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—HPGDS—lung cancer	4.36e-06	5.78e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ENO2—lung cancer	4.36e-06	5.78e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—PIK3CA—lung cancer	4.35e-06	5.76e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PPP2R1B—lung cancer	4.33e-06	5.74e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—NQO1—lung cancer	4.32e-06	5.72e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—POMC—lung cancer	4.29e-06	5.68e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.28e-06	5.67e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GSTP1—lung cancer	4.26e-06	5.64e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ENO1—lung cancer	4.24e-06	5.62e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.24e-06	5.62e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MDM2—lung cancer	4.23e-06	5.61e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTA3—lung cancer	4.23e-06	5.61e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—RRM1—lung cancer	4.23e-06	5.61e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTT1—lung cancer	4.23e-06	5.61e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.23e-06	5.6e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—RAF1—lung cancer	4.22e-06	5.59e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.19e-06	5.55e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP2A6—lung cancer	4.18e-06	5.54e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GCLC—lung cancer	4.18e-06	5.54e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—CREBBP—lung cancer	4.17e-06	5.53e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—ERBB2—lung cancer	4.17e-06	5.53e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.17e-06	5.52e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CAT—lung cancer	4.14e-06	5.49e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PIK3CB—lung cancer	4.12e-06	5.46e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MTOR—lung cancer	4.12e-06	5.46e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CD4—lung cancer	4.11e-06	5.45e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PTGS2—lung cancer	4.08e-06	5.41e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ABCB1—lung cancer	4.03e-06	5.34e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—HRAS—lung cancer	4.02e-06	5.33e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—B4GALT5—lung cancer	3.98e-06	5.27e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	3.97e-06	5.26e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ENO1—lung cancer	3.96e-06	5.25e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CD—lung cancer	3.96e-06	5.24e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—TYMS—lung cancer	3.96e-06	5.24e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.95e-06	5.23e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GSTM1—lung cancer	3.91e-06	5.18e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—ALB—lung cancer	3.91e-06	5.18e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.9e-06	5.17e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—STK11—lung cancer	3.89e-06	5.16e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTA4—lung cancer	3.87e-06	5.13e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—IL6—lung cancer	3.85e-06	5.1e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP2E1—lung cancer	3.81e-06	5.04e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PTEN—lung cancer	3.8e-06	5.04e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTA2—lung cancer	3.77e-06	5e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NQO1—lung cancer	3.76e-06	4.99e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CYP1A1—lung cancer	3.71e-06	4.91e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ERCC2—lung cancer	3.68e-06	4.87e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.66e-06	4.84e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PIK3CA—lung cancer	3.64e-06	4.82e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTA1—lung cancer	3.64e-06	4.82e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—EP300—lung cancer	3.63e-06	4.81e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GSTP1—lung cancer	3.6e-06	4.77e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ABCC3—lung cancer	3.6e-06	4.77e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	3.59e-06	4.76e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CDKN1A—lung cancer	3.57e-06	4.73e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PTEN—lung cancer	3.56e-06	4.72e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP2E1—lung cancer	3.56e-06	4.71e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—AKT1—lung cancer	3.55e-06	4.71e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NQO1—lung cancer	3.52e-06	4.66e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CAT—lung cancer	3.51e-06	4.65e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.49e-06	4.62e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—AKR1C1—lung cancer	3.48e-06	4.62e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CB—lung cancer	3.45e-06	4.57e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.44e-06	4.56e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PTGS2—lung cancer	3.42e-06	4.53e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.41e-06	4.52e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ABCB1—lung cancer	3.41e-06	4.52e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—EP300—lung cancer	3.39e-06	4.5e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—STK11—lung cancer	3.39e-06	4.49e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—UGT1A1—lung cancer	3.38e-06	4.48e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—TYMS—lung cancer	3.35e-06	4.44e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GSTM1—lung cancer	3.31e-06	4.39e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—SRC—lung cancer	3.3e-06	4.37e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GNG11—lung cancer	3.26e-06	4.32e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—STAT3—lung cancer	3.18e-06	4.22e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—APOA1—lung cancer	3.18e-06	4.21e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—NRAS—lung cancer	3.18e-06	4.21e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—STK11—lung cancer	3.17e-06	4.2e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GSTP1—lung cancer	3.14e-06	4.16e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP1A1—lung cancer	3.14e-06	4.16e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ERCC2—lung cancer	3.11e-06	4.12e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ALDOA—lung cancer	3.11e-06	4.12e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CAT—lung cancer	3.05e-06	4.05e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MAPK3—lung cancer	3.04e-06	4.03e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NCOA3—lung cancer	3.02e-06	4e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PTEN—lung cancer	2.98e-06	3.95e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.97e-06	3.94e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—AKT1—lung cancer	2.97e-06	3.94e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MYC—lung cancer	2.96e-06	3.92e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ADCY1—lung cancer	2.93e-06	3.89e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ABCG2—lung cancer	2.93e-06	3.89e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTP1—lung cancer	2.93e-06	3.89e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—TYMS—lung cancer	2.92e-06	3.87e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CG—lung cancer	2.9e-06	3.85e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—EGFR—lung cancer	2.89e-06	3.83e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GSTM1—lung cancer	2.88e-06	3.82e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ENO2—lung cancer	2.88e-06	3.81e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—HPGDS—lung cancer	2.88e-06	3.81e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.86e-06	3.79e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CAT—lung cancer	2.85e-06	3.78e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—EP300—lung cancer	2.84e-06	3.77e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.84e-06	3.76e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTT1—lung cancer	2.79e-06	3.7e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ABCB1—lung cancer	2.78e-06	3.68e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—POMC—lung cancer	2.76e-06	3.66e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP2A6—lung cancer	2.76e-06	3.65e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GCLC—lung cancer	2.76e-06	3.65e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP1A1—lung cancer	2.73e-06	3.62e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—KRAS—lung cancer	2.73e-06	3.62e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—TYMS—lung cancer	2.73e-06	3.61e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ERCC2—lung cancer	2.71e-06	3.59e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTM1—lung cancer	2.69e-06	3.57e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—APOA1—lung cancer	2.69e-06	3.57e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CREBBP—lung cancer	2.69e-06	3.57e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PIK3CA—lung cancer	2.68e-06	3.56e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ENO1—lung cancer	2.61e-06	3.46e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.58e-06	3.42e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP1A1—lung cancer	2.55e-06	3.38e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CD—lung cancer	2.55e-06	3.38e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ERCC2—lung cancer	2.53e-06	3.36e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ALB—lung cancer	2.52e-06	3.34e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PIK3CA—lung cancer	2.51e-06	3.33e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CG—lung cancer	2.46e-06	3.26e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—APOA1—lung cancer	2.35e-06	3.11e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP2E1—lung cancer	2.34e-06	3.11e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—POMC—lung cancer	2.34e-06	3.1e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—HRAS—lung cancer	2.32e-06	3.08e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NQO1—lung cancer	2.32e-06	3.07e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CREBBP—lung cancer	2.28e-06	3.02e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CB—lung cancer	2.23e-06	2.95e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—IL6—lung cancer	2.22e-06	2.95e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PTGS2—lung cancer	2.2e-06	2.92e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—AKT1—lung cancer	2.19e-06	2.91e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—APOA1—lung cancer	2.19e-06	2.9e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CD—lung cancer	2.16e-06	2.86e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CG—lung cancer	2.14e-06	2.84e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ALB—lung cancer	2.13e-06	2.83e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CA—lung cancer	2.1e-06	2.79e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.1e-06	2.78e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—STK11—lung cancer	2.09e-06	2.77e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—AKT1—lung cancer	2.05e-06	2.72e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—POMC—lung cancer	2.04e-06	2.7e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CG—lung cancer	2e-06	2.65e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CREBBP—lung cancer	1.99e-06	2.63e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTP1—lung cancer	1.93e-06	2.56e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PTEN—lung cancer	1.92e-06	2.55e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—POMC—lung cancer	1.9e-06	2.52e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CB—lung cancer	1.88e-06	2.5e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CD—lung cancer	1.88e-06	2.49e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CAT—lung cancer	1.88e-06	2.49e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PTGS2—lung cancer	1.87e-06	2.47e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ALB—lung cancer	1.86e-06	2.46e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CREBBP—lung cancer	1.86e-06	2.46e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—EP300—lung cancer	1.83e-06	2.43e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ABCB1—lung cancer	1.83e-06	2.43e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—TYMS—lung cancer	1.8e-06	2.38e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTM1—lung cancer	1.78e-06	2.35e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CD—lung cancer	1.76e-06	2.33e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ALB—lung cancer	1.74e-06	2.3e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—AKT1—lung cancer	1.72e-06	2.28e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP1A1—lung cancer	1.68e-06	2.23e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ERCC2—lung cancer	1.67e-06	2.21e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CB—lung cancer	1.64e-06	2.17e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PTEN—lung cancer	1.63e-06	2.16e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PTGS2—lung cancer	1.63e-06	2.15e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—EP300—lung cancer	1.55e-06	2.06e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CB—lung cancer	1.53e-06	2.03e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PTGS2—lung cancer	1.52e-06	2.01e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—APOA1—lung cancer	1.45e-06	1.92e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PTEN—lung cancer	1.42e-06	1.88e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CA—lung cancer	1.36e-06	1.8e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—EP300—lung cancer	1.35e-06	1.79e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PTEN—lung cancer	1.32e-06	1.76e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CG—lung cancer	1.32e-06	1.75e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—EP300—lung cancer	1.26e-06	1.67e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—POMC—lung cancer	1.26e-06	1.66e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CREBBP—lung cancer	1.22e-06	1.62e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CD—lung cancer	1.16e-06	1.54e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CA—lung cancer	1.15e-06	1.52e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ALB—lung cancer	1.15e-06	1.52e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—AKT1—lung cancer	1.11e-06	1.47e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CB—lung cancer	1.01e-06	1.34e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PTGS2—lung cancer	1e-06	1.33e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CA—lung cancer	1e-06	1.33e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—AKT1—lung cancer	9.38e-07	1.24e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CA—lung cancer	9.35e-07	1.24e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PTEN—lung cancer	8.74e-07	1.16e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—EP300—lung cancer	8.33e-07	1.1e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—AKT1—lung cancer	8.17e-07	1.08e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—AKT1—lung cancer	7.63e-07	1.01e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CA—lung cancer	6.16e-07	8.17e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—AKT1—lung cancer	5.04e-07	6.67e-06	CbGpPWpGaD
